Screening Cardiovascular Patients for Aortic Aneurysms (SCAN)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Screening studies for Abdominal Aortic Aneurysms (AAA) in 65 to 79 years aged men, have shown a significant reduction in AAA related mortality. In addition, the cost-effectiveness of screening for AAA in men in the Netherlands has been demonstrated by using a Markov model. Screening might be even more (cost-) effective if targeted on high risk groups, such as patients with a particular cardiovascular disease with a known increased risk of having an AAA.
Project SCAN (Screening CardioVascular patients for Aortic aNeurysms) is a project focused on targeted AAA screening to proactively diagnose patients at high risk of having an aneurysm that eventually may rupture. This pilot project aims to study the value of a screening protocol in daily practice to detect AAA's in high risk patients.
| Condition |
|---|
|
Abdominal Aortic Aneurysm |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Screening Cardiovascular Patients for Aortic Aneurysms |
- AAA prevalence [ Time Frame: 1 year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1 |
| Study Start Date: | July 2012 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
- Offering PAD and CAD patients a non-invasive abdominal ultrasound after a careful process of shared-decision making
Recording data on aneurysm detection on all PAD and CAD patients screened:
- General information (age, gender)
- Medical history on CardioVascular risk factors (such as smoking history, hypertension, and other cardiovascular medical conditions - only information that is already recorded in the patient's medical history chart)
- AAA - Yes/ No (Yes if ≥3 cm AAA)
- If ≥3 cm aneurysm, record exact size and outcome in time (surveillance, treatment, no treatment)
- If treated, record treatment type (EVAR or Open) and outcome
Eligibility| Ages Eligible for Study: | 55 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with peripheral arterial disease or carotid arterial disease
Inclusion Criteria:
- male and female patients
- peripheral arterial disease (ankle brachial index < 0,90 and/or reduction of > 0.15 after exercise test) or a carotid stenosis (stenosis ≥ 50%)
- age > 55 year
Exclusion Criteria:
- Patients unfit for endovascular or open surgery (as judged by vascular surgeon)
- Failure to master the dutch language
Contacts and Locations| Netherlands | |
| Catharina Hospital | Recruiting |
| Eindhoven, Netherlands | |
| Contact: Nicole Verhofstad, PhD 0031 402396349 nicole.verhofstad@catharinaziekenhuis.nl | |
| Principal Investigator: Joep Teijink, MD, PhD | |
More Information
No publications provided
| Responsible Party: | Joep Teijink, MD, PhD, Vascular Surgeon, Catharina Ziekenhuis Eindhoven |
| ClinicalTrials.gov Identifier: | NCT01643317 History of Changes |
| Other Study ID Numbers: | Catharina_Project_SCAN |
| Study First Received: | July 16, 2012 |
| Last Updated: | May 23, 2013 |
| Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Additional relevant MeSH terms:
|
Aneurysm Aortic Aneurysm Aortic Aneurysm, Abdominal |
Vascular Diseases Cardiovascular Diseases Aortic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013